DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of “Hold” from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been assigned a consensus recommendation of “Hold” from the twelve ratings firms that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $27.91.

A number of brokerages have recently issued reports on XRAY. Barrington Research reduced their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Morgan Stanley decreased their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. Mizuho began coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Finally, Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th.

DENTSPLY SIRONA Stock Up 1.2 %

XRAY opened at $18.70 on Monday. The stock’s fifty day simple moving average is $20.72 and its 200 day simple moving average is $23.90. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $37.60. The stock has a market cap of $3.72 billion, a PE ratio of -9.03, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company’s revenue was up .4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 earnings per share. As a group, research analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.42%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. UMB Bank n.a. raised its holdings in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in DENTSPLY SIRONA during the third quarter worth about $27,000. LRI Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares during the last quarter. Kennebec Savings Bank acquired a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $35,000. Finally, Rothschild Investment LLC bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at approximately $32,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.